Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if Parasol punctal occluders (Brand A) have a higher rate of retention than Superflex punctal plugs (Brand B).


Clinical Trial Description

Eyes will be randomized to either Brand A or Brand B punctal plug. The primary outcome measure is length of time punctual plugs are retained, measured in weeks. This will be measured at weekly assessments for 6 months. Secondary outcome measures include patient satisfaction, and improvement in subjective and objective dry eye scores, as well as complications related to punctual plugs including spontaneous plug loss, and intolerance. We will evaluate these measures by repeating the Canadian Dry Eye Assessment, Schirmer 1, tear meniscus height, fluorescein corneal staining (NEI scale), and lissamine green conjunctival staining (NEI scale) at month 1, month 3, and month 6 visits. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01947517
Study type Observational
Source Queen's University
Contact Ashley R Brissette, BSc, MD
Phone 613 544 3310
Email abrissette@qmed.ca
Status Recruiting
Phase N/A
Start date September 2013
Completion date August 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04775303 - A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING) Phase 4
Completed NCT01311609 - A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients Phase 4